Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Mark Abzug

Concepts (408)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Enterovirus Infections
21
2019
160
2.940
Why?
HIV Infections
27
2022
2453
2.000
Why?
Antiretroviral Therapy, Highly Active
9
2017
256
1.760
Why?
Pneumococcal Vaccines
5
2021
131
1.700
Why?
Antiviral Agents
11
2021
642
1.530
Why?
Pregnancy Complications, Infectious
14
2015
285
1.510
Why?
Enterovirus
9
2019
72
1.240
Why?
Hematopoietic Stem Cell Transplantation
4
2021
519
1.070
Why?
Immunologic Memory
3
2013
313
1.000
Why?
Pneumococcal Infections
3
2013
91
0.960
Why?
Immunization, Secondary
4
2021
82
0.940
Why?
Oxadiazoles
4
2015
32
0.870
Why?
Paralysis
4
2018
66
0.760
Why?
Child
54
2023
18400
0.720
Why?
Sinusitis
7
2013
174
0.630
Why?
Vaccination
4
2017
1202
0.610
Why?
Triazoles
2
2018
125
0.610
Why?
Anti-Retroviral Agents
8
2022
207
0.600
Why?
Mucositis
1
2018
18
0.600
Why?
Meningoencephalitis
1
2017
24
0.580
Why?
Influenza, Human
5
2015
543
0.570
Why?
Antibodies, Bacterial
4
2013
119
0.570
Why?
Myelitis
4
2019
88
0.570
Why?
Theilovirus
4
2000
5
0.540
Why?
Encephalitis
1
2017
126
0.520
Why?
Graft vs Host Disease
1
2018
212
0.520
Why?
Influenza A Virus, H1N1 Subtype
3
2015
138
0.520
Why?
Neonatal Sepsis
1
2015
4
0.490
Why?
Central Nervous System Viral Diseases
4
2019
63
0.490
Why?
Encephalomyelitis, Acute Disseminated
1
2015
13
0.490
Why?
Immunocompromised Host
5
2021
192
0.480
Why?
Herpes Simplex
4
2017
87
0.480
Why?
Disease Outbreaks
6
2019
305
0.480
Why?
Influenza Vaccines
3
2015
497
0.470
Why?
Placenta
6
2000
628
0.450
Why?
Humans
87
2023
114043
0.450
Why?
Infant, Newborn
25
2018
5038
0.440
Why?
Neuromyelitis Optica
1
2015
115
0.440
Why?
Child, Preschool
27
2022
9114
0.440
Why?
CD4 Lymphocyte Count
8
2022
256
0.430
Why?
Adolescent
35
2022
17800
0.430
Why?
Neuromuscular Diseases
3
2019
89
0.430
Why?
Infant
26
2020
7943
0.420
Why?
Drug Discovery
1
2013
123
0.410
Why?
Measles Vaccine
1
2012
17
0.410
Why?
Female
61
2022
59325
0.400
Why?
Male
52
2022
55396
0.400
Why?
Mucormycosis
3
2005
20
0.400
Why?
RNA, Viral
12
2013
565
0.390
Why?
Anti-HIV Agents
5
2022
663
0.370
Why?
Meningococcal Vaccines
2
2012
48
0.360
Why?
Cardiovirus Infections
2
2000
3
0.360
Why?
Viral Vaccines
2
2009
88
0.350
Why?
Candidemia
2
2023
7
0.340
Why?
Oxazoles
4
2015
29
0.340
Why?
Viral Load
7
2017
405
0.340
Why?
Candidiasis, Invasive
2
2023
5
0.330
Why?
Hepatitis B Vaccines
1
2009
46
0.320
Why?
AIDS-Related Opportunistic Infections
3
2015
115
0.320
Why?
Bacterial Vaccines
1
2009
61
0.310
Why?
Fatigue Syndrome, Chronic
1
2008
16
0.300
Why?
Pertussis Vaccine
1
2007
21
0.290
Why?
Communicable Diseases, Emerging
1
2008
28
0.290
Why?
Poliomyelitis
2
1997
27
0.290
Why?
Mycetoma
2
2004
6
0.280
Why?
Viremia
5
2021
122
0.270
Why?
Fetus
3
2000
698
0.270
Why?
Rhinitis
3
2009
128
0.270
Why?
Immunoglobulins, Intravenous
3
1997
122
0.270
Why?
Pregnancy
16
2021
5499
0.260
Why?
Anti-Bacterial Agents
3
2013
1471
0.250
Why?
Antibodies, Viral
5
2022
520
0.250
Why?
Antifungal Agents
4
2023
128
0.250
Why?
Enterovirus B, Human
3
2001
24
0.230
Why?
Meningitis, Viral
2
2004
21
0.230
Why?
Maxillary Sinusitis
2
2004
7
0.230
Why?
Maus Elberfeld virus
3
1993
5
0.220
Why?
Global Health
2
2018
284
0.220
Why?
Cytomegalovirus
2
2016
143
0.220
Why?
Interferon-gamma
2
2015
719
0.210
Why?
Acquired Immunodeficiency Syndrome
2
2017
212
0.210
Why?
Placenta Diseases
2
1995
13
0.200
Why?
Fetal Diseases
3
2000
146
0.200
Why?
Centralized Hospital Services
1
2001
6
0.190
Why?
United States
13
2021
12137
0.190
Why?
Pneumonia, Viral
2
2021
334
0.190
Why?
Retrospective Studies
14
2022
12521
0.190
Why?
Oseltamivir
2
2012
11
0.190
Why?
Hepatitis, Viral, Human
1
2001
25
0.190
Why?
Colorado
7
2021
4090
0.190
Why?
Research Support as Topic
1
2001
107
0.180
Why?
Young Adult
14
2017
10444
0.180
Why?
Streptococcus pneumoniae
3
2014
133
0.180
Why?
Ethmoid Sinusitis
1
1999
1
0.170
Why?
Intracranial Hemorrhages
1
2000
76
0.170
Why?
Hydrops Fetalis
1
1999
13
0.170
Why?
Neurodevelopmental Disorders
1
2021
110
0.170
Why?
Uterine Diseases
1
1999
14
0.170
Why?
Blood Coagulation Disorders
1
2001
154
0.170
Why?
Polymerase Chain Reaction
4
2016
990
0.160
Why?
Follow-Up Studies
8
2022
4392
0.160
Why?
Embryonic Development
1
2000
117
0.160
Why?
Drug Resistance, Microbial
1
1999
66
0.160
Why?
Mastoiditis
2
2014
5
0.160
Why?
Nervous System Diseases
2
2019
254
0.150
Why?
Enterovirus D, Human
2
2018
72
0.150
Why?
Fluoxetine
1
2018
46
0.150
Why?
Double-Blind Method
3
2015
1656
0.150
Why?
Antibodies, Monoclonal
2
2022
1257
0.150
Why?
Heptavalent Pneumococcal Conjugate Vaccine
2
2009
11
0.150
Why?
Hospitals, Pediatric
1
2001
478
0.150
Why?
Enzyme-Linked Immunosorbent Assay
2
2013
787
0.150
Why?
HIV-1
2
2015
768
0.150
Why?
Biliary Atresia
1
2020
185
0.150
Why?
Treatment Outcome
9
2020
9049
0.150
Why?
Arboviruses
1
2017
10
0.150
Why?
Nucleic Acid Hybridization
6
1991
187
0.150
Why?
In Situ Hybridization
4
2000
292
0.150
Why?
Postoperative Complications
2
2016
2122
0.150
Why?
Administration, Intravenous
1
2018
122
0.140
Why?
Disease Transmission, Infectious
1
2018
54
0.140
Why?
Allografts
1
2018
121
0.140
Why?
Risk Factors
11
2023
8614
0.140
Why?
Acyclovir
2
2015
100
0.140
Why?
Practice Guidelines as Topic
2
2022
1381
0.140
Why?
Endoscopy
1
1999
245
0.140
Why?
Brain
3
2017
2355
0.140
Why?
Clinical Trials as Topic
1
2001
926
0.140
Why?
Sexual Maturation
1
2017
47
0.140
Why?
Immunization, Passive
1
1997
73
0.140
Why?
Adult
17
2022
30375
0.140
Why?
Cytomegalovirus Retinitis
1
2016
16
0.140
Why?
Gastrointestinal Diseases
1
2018
182
0.130
Why?
Antibodies, Neutralizing
2
2022
222
0.130
Why?
Diagnosis, Differential
2
2017
1331
0.130
Why?
DNA, Viral
2
2016
349
0.130
Why?
Nasal Mucosa
2
2009
93
0.130
Why?
Hyperlipidemias
1
2017
121
0.130
Why?
Adoption
1
2016
38
0.130
Why?
Child Development
2
2017
384
0.130
Why?
Respiratory Syncytial Virus Infections
1
1997
97
0.130
Why?
Mice, Inbred ICR
4
1997
108
0.130
Why?
Congenital Abnormalities
2
2010
72
0.130
Why?
Sexually Transmitted Diseases
1
2017
154
0.130
Why?
Lymphocyte Subsets
1
2015
79
0.120
Why?
Incidence
6
2017
2314
0.120
Why?
Ganciclovir
1
2015
48
0.120
Why?
Chi-Square Distribution
2
2013
492
0.120
Why?
Oropharynx
1
2015
36
0.120
Why?
Lymphopenia
1
2015
49
0.120
Why?
Muscle Hypotonia
1
2015
31
0.120
Why?
Cohort Studies
6
2023
4883
0.120
Why?
Cranial Nerve Diseases
1
2015
42
0.120
Why?
Adenovirus Infections, Human
2
1991
12
0.120
Why?
Hearing Loss, Sensorineural
1
2015
54
0.120
Why?
Rectum
1
2015
151
0.110
Why?
Mycoses
1
2014
66
0.110
Why?
Controlled Clinical Trials as Topic
1
2013
27
0.110
Why?
Beclomethasone
1
1993
25
0.110
Why?
Intensive Care Units, Pediatric
1
2015
148
0.110
Why?
Puberty, Delayed
1
2013
4
0.110
Why?
Liver Transplantation
1
2020
695
0.110
Why?
Antibody Affinity
1
2013
51
0.110
Why?
Giant Cells
1
1993
21
0.110
Why?
Hemagglutination Inhibition Tests
1
2013
37
0.110
Why?
CD4-Positive T-Lymphocytes
2
2017
959
0.100
Why?
Cytomegalovirus Infections
1
2015
180
0.100
Why?
Candida
1
2012
32
0.100
Why?
Orthomyxoviridae
1
2012
35
0.100
Why?
Chickenpox
1
1993
93
0.100
Why?
Viral Plaque Assay
1
2012
24
0.100
Why?
Hospital Design and Construction
1
1992
3
0.100
Why?
Severity of Illness Index
4
2021
2537
0.100
Why?
Neutralization Tests
1
2012
63
0.100
Why?
Bacterial Infections
2
2009
217
0.100
Why?
Gestational Age
4
2015
761
0.100
Why?
Aircraft
1
1992
27
0.100
Why?
Drug Resistance, Viral
1
2012
99
0.100
Why?
HIV
1
2013
208
0.100
Why?
Ureaplasma urealyticum
1
1991
3
0.100
Why?
Prospective Studies
7
2017
6195
0.100
Why?
Decision Support Techniques
1
2015
336
0.100
Why?
Chlamydia trachomatis
1
1991
35
0.100
Why?
Chorioamnionitis
1
1991
36
0.090
Why?
Biomarkers
1
2021
3397
0.090
Why?
Trophoblasts
1
1993
165
0.090
Why?
Maternal-Fetal Exchange
2
2007
151
0.090
Why?
Peritoneovenous Shunt
1
1990
1
0.090
Why?
Meningitis, Aseptic
1
1990
15
0.090
Why?
Poliovirus Vaccine, Oral
1
1990
19
0.090
Why?
Rimantadine
1
2010
1
0.090
Why?
Legionnaires' Disease
1
1990
4
0.090
Why?
Cross Infection
1
1992
194
0.090
Why?
Adamantane
1
2010
15
0.090
Why?
Mice
8
2000
14841
0.090
Why?
T-Lymphocytes
2
2015
1735
0.080
Why?
Poliovirus
1
1990
77
0.080
Why?
Hepatitis B Antibodies
1
2009
10
0.080
Why?
Respiratory Tract Infections
3
2016
319
0.080
Why?
Meningitis
1
1990
74
0.080
Why?
Administration, Oral
3
2012
725
0.080
Why?
Age Factors
4
2017
2885
0.080
Why?
South Africa
1
2009
160
0.080
Why?
Maxillary Sinus
2
2009
11
0.080
Why?
Acute Kidney Injury
1
2015
637
0.080
Why?
Mucor
2
2005
7
0.080
Why?
Body Fluids
1
1987
58
0.070
Why?
Evidence-Based Medicine
3
2021
662
0.070
Why?
Drug Administration Schedule
2
2015
714
0.070
Why?
Antibodies, Monoclonal, Humanized
2
2022
660
0.070
Why?
Reverse Transcriptase Inhibitors
1
2007
82
0.070
Why?
Aspergillosis
2
2014
23
0.070
Why?
Virus Diseases
1
2009
195
0.070
Why?
Organ Transplantation
1
2009
159
0.070
Why?
Mitochondrial Diseases
1
2007
76
0.070
Why?
Zygomycosis
1
2006
6
0.070
Why?
Carotid Artery Thrombosis
1
2005
7
0.060
Why?
Chronic Disease
5
2009
1577
0.060
Why?
Logistic Models
2
2023
1829
0.060
Why?
Animals
9
2000
31565
0.060
Why?
Longitudinal Studies
3
2018
2384
0.060
Why?
Randomized Controlled Trials as Topic
2
2004
1204
0.060
Why?
Statistics as Topic
1
2006
291
0.060
Why?
Drug Therapy, Combination
2
2007
949
0.060
Why?
International Cooperation
2
2018
169
0.060
Why?
Scedosporium
1
2004
1
0.060
Why?
Herpesvirus 7, Human
1
2004
6
0.060
Why?
Drug Resistance, Fungal
1
2004
9
0.060
Why?
Roseolovirus Infections
1
2004
7
0.060
Why?
Herpesvirus 6, Human
1
2004
13
0.060
Why?
Granulocyte Colony-Stimulating Factor
1
2004
70
0.060
Why?
Respiratory Syncytial Viruses
2
1997
46
0.060
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2004
140
0.060
Why?
Vaccines, Conjugate
2
2014
59
0.050
Why?
Infant, Premature, Diseases
2
1997
88
0.050
Why?
Biological Availability
1
2003
119
0.050
Why?
Risk Assessment
2
2020
2958
0.050
Why?
Disease Models, Animal
3
2000
3498
0.050
Why?
Probability
1
2003
286
0.050
Why?
Case-Control Studies
3
2015
3003
0.050
Why?
Prenatal Exposure Delayed Effects
1
2007
453
0.050
Why?
Growth Disorders
1
2022
77
0.050
Why?
Reference Values
1
2003
739
0.050
Why?
Drug Combinations
1
2022
286
0.050
Why?
Bacteria, Aerobic
1
2001
7
0.050
Why?
Personnel Staffing and Scheduling
1
2001
79
0.050
Why?
Income
1
2022
167
0.050
Why?
RNA
2
2022
807
0.050
Why?
Adenosine Monophosphate
1
2021
49
0.050
Why?
Drug Approval
1
2021
78
0.040
Why?
Alanine
1
2021
105
0.040
Why?
Systemic Inflammatory Response Syndrome
1
2021
68
0.040
Why?
United States Food and Drug Administration
1
2021
172
0.040
Why?
RNA Probes
2
1991
13
0.040
Why?
Disseminated Intravascular Coagulation
1
2000
29
0.040
Why?
Picornaviridae Infections
2
1990
29
0.040
Why?
Necrosis
1
2000
209
0.040
Why?
Remission Induction
1
2020
233
0.040
Why?
Amniotic Fluid
2
1991
64
0.040
Why?
Fungi
2
2014
124
0.040
Why?
Otitis Media with Effusion
1
1999
21
0.040
Why?
Cerebrospinal Fluid
2
2004
90
0.040
Why?
Pharyngitis
1
1999
23
0.040
Why?
Time Factors
1
2009
6077
0.040
Why?
Pseudallescheria
1
1999
3
0.040
Why?
Diabetes Mellitus, Type 1
2
2005
3254
0.040
Why?
Dose-Response Relationship, Drug
1
2003
1836
0.040
Why?
Zidovudine
2
2010
77
0.040
Why?
Opportunistic Infections
1
1999
43
0.040
Why?
Living Donors
1
2020
270
0.040
Why?
Spinal Cord
1
2000
344
0.040
Why?
Sex Factors
2
2017
1706
0.040
Why?
Chlamydiaceae Infections
1
2017
1
0.040
Why?
Epidemiological Monitoring
1
2018
46
0.040
Why?
Nutrition Disorders
1
1997
22
0.040
Why?
B-Lymphocytes
2
2015
762
0.040
Why?
Reoperation
1
1999
513
0.040
Why?
Tissue and Organ Procurement
1
2020
226
0.040
Why?
Internationality
1
2018
143
0.040
Why?
Abortion, Spontaneous
1
1997
89
0.030
Why?
Otitis Media
1
1999
142
0.030
Why?
Heart
1
2000
613
0.030
Why?
Ophthalmoscopy
1
2016
30
0.030
Why?
Antigens, Viral
1
2017
176
0.030
Why?
Acute Disease
1
1999
907
0.030
Why?
Encephalomyelitis
1
2016
9
0.030
Why?
Plasma Cells
2
2009
56
0.030
Why?
Multicenter Studies as Topic
1
1997
249
0.030
Why?
Immune Tolerance
2
1999
321
0.030
Why?
Enzyme-Linked Immunospot Assay
1
2015
34
0.030
Why?
North America
1
2016
255
0.030
Why?
AIDS Dementia Complex
1
2015
50
0.030
Why?
Caribbean Region
1
2015
19
0.030
Why?
Molecular Diagnostic Techniques
1
2016
92
0.030
Why?
Malnutrition
1
2016
62
0.030
Why?
Transplantation, Homologous
1
2016
377
0.030
Why?
Physical Conditioning, Animal
1
1997
194
0.030
Why?
Audiometry
1
2015
26
0.030
Why?
Biopsy
3
2009
1024
0.030
Why?
Encephalitis, Herpes Simplex
1
2015
19
0.030
Why?
Encephalitis, Varicella Zoster
1
2015
20
0.030
Why?
Latin America
1
2015
68
0.030
Why?
Patient Outcome Assessment
1
2016
122
0.030
Why?
Evaluation Studies as Topic
1
1995
167
0.030
Why?
Hematologic Neoplasms
1
2016
136
0.030
Why?
Coinfection
1
2016
120
0.030
Why?
Odds Ratio
1
2017
951
0.030
Why?
C-Reactive Protein
1
2017
362
0.030
Why?
Canada
1
2015
320
0.030
Why?
Papillomavirus Vaccines
1
2017
222
0.030
Why?
Combined Modality Therapy
3
2005
1117
0.030
Why?
Microscopy, Electron
1
1995
408
0.030
Why?
Neutropenia
1
2015
123
0.030
Why?
Metabolic Diseases
1
2015
98
0.030
Why?
Evoked Potentials, Auditory, Brain Stem
1
2015
47
0.030
Why?
Papillomavirus Infections
1
2017
261
0.030
Why?
Infusions, Intravenous
1
2015
370
0.030
Why?
Multivariate Analysis
1
2017
1422
0.030
Why?
Prognosis
1
2001
3315
0.030
Why?
Administration, Intranasal
1
1993
75
0.030
Why?
Mortality
1
2015
283
0.030
Why?
Sexual Behavior
1
2017
434
0.030
Why?
Tomography, X-Ray Computed
2
1999
2272
0.030
Why?
Sequence Analysis, DNA
1
2016
722
0.030
Why?
Infant, Premature
1
1997
478
0.030
Why?
Electromyography
1
2015
326
0.030
Why?
Pandemics
1
2021
1310
0.030
Why?
T-Lymphocyte Subsets
1
2015
383
0.030
Why?
Epidemiologic Studies
1
2012
57
0.030
Why?
Aged, 80 and over
1
2023
6306
0.030
Why?
Oncology Service, Hospital
1
1992
15
0.030
Why?
Neisseria meningitidis
1
2012
18
0.030
Why?
Meningococcal Infections
1
2012
20
0.020
Why?
Ventilation
1
1992
31
0.020
Why?
Ureaplasma Infections
1
1991
3
0.020
Why?
Europe
1
2012
332
0.020
Why?
Amniocentesis
1
1991
21
0.020
Why?
Mycoplasma Infections
1
1991
13
0.020
Why?
Flow Cytometry
1
2015
1075
0.020
Why?
Microbial Viability
1
2012
79
0.020
Why?
Comorbidity
1
2016
1447
0.020
Why?
Adenoviruses, Human
1
1991
24
0.020
Why?
Lymphocyte Activation
1
2015
1036
0.020
Why?
Hospitals, University
1
1991
169
0.020
Why?
Anti-Infective Agents
1
2013
219
0.020
Why?
Paramyxoviridae Infections
1
1990
10
0.020
Why?
Respirovirus Infections
1
1990
21
0.020
Why?
Chlamydia Infections
1
1991
63
0.020
Why?
Rhinovirus
1
1990
40
0.020
Why?
Immunohistochemistry
1
1995
1624
0.020
Why?
Population Surveillance
1
1993
385
0.020
Why?
Sensitivity and Specificity
1
1995
1690
0.020
Why?
Inpatients
1
2014
378
0.020
Why?
Benzoxazines
1
2010
28
0.020
Why?
Cyclopropanes
1
2010
81
0.020
Why?
Alkynes
1
2010
53
0.020
Why?
Legionella
1
1990
7
0.020
Why?
Cells, Cultured
1
1997
3861
0.020
Why?
Magnetic Resonance Imaging
2
2015
3039
0.020
Why?
Leukemia
1
1992
208
0.020
Why?
Dermatomyositis
1
1989
23
0.020
Why?
Hospitals
1
2014
581
0.020
Why?
Peroxidase
1
2009
161
0.020
Why?
Respiratory Tract Diseases
1
1990
139
0.020
Why?
Staining and Labeling
1
2009
134
0.020
Why?
Seasons
1
1990
440
0.020
Why?
Natural Killer T-Cells
1
2009
63
0.020
Why?
Muscles
1
1989
320
0.020
Why?
Central Nervous System
1
2010
230
0.020
Why?
Picornaviridae
1
1988
17
0.020
Why?
Ribonucleases
1
1987
52
0.020
Why?
HIV Reverse Transcriptase
1
2007
29
0.020
Why?
Lamivudine
1
2007
59
0.020
Why?
Antigens, CD
1
2009
440
0.020
Why?
Cross-Sectional Studies
1
2016
4402
0.020
Why?
Cavernous Sinus
1
2005
14
0.020
Why?
Telencephalon
1
2005
15
0.020
Why?
Infectious Disease Transmission, Vertical
1
2007
150
0.020
Why?
Orbit
1
2005
52
0.020
Why?
Paranasal Sinuses
1
2005
66
0.020
Why?
Prevalence
1
2010
2247
0.010
Why?
Exocrine Glands
1
2004
4
0.010
Why?
Basement Membrane
1
2004
30
0.010
Why?
Neutrophils
1
2009
1089
0.010
Why?
Cell Count
1
2004
303
0.010
Why?
Lymphocytes
1
2004
327
0.010
Why?
Macrophages
1
2009
1259
0.010
Why?
Eosinophils
1
2004
276
0.010
Why?
Penicillin Resistance
1
2001
8
0.010
Why?
Haemophilus influenzae
1
2001
48
0.010
Why?
beta-Lactamases
1
2001
25
0.010
Why?
Drug Resistance, Multiple, Bacterial
1
2001
61
0.010
Why?
Staphylococcus
1
2001
69
0.010
Why?
Drug Resistance, Bacterial
1
2001
156
0.010
Why?
Nasal Decongestants
1
1999
8
0.010
Why?
Otorhinolaryngologic Surgical Procedures
1
1999
33
0.010
Why?
Steroids
1
1999
143
0.010
Why?
Recurrence
1
1999
925
0.010
Why?
Anti-Inflammatory Agents
1
1999
445
0.010
Why?
Patient Selection
1
1999
629
0.010
Why?
RNA, Antisense
1
1988
17
0.000
Why?
DNA, Recombinant
1
1988
41
0.000
Why?
Sequence Homology, Nucleic Acid
1
1988
152
0.000
Why?
Aged
1
2006
18969
0.000
Why?
Virus Replication
1
1988
395
0.000
Why?
Middle Aged
1
2006
26605
0.000
Why?
Cell Line
1
1988
2629
0.000
Why?
DNA
1
1988
1350
0.000
Why?
Abzug's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)